STAT

HHS opens door to possibility of importing some drugs to drive down prices

In an early but striking move, the Trump administration is opening the door to possibility of importing drugs in limited cases.
Secretary of Health and Human Services Alex Azar

WASHINGTON — The Trump administration is opening up the door to importing prescription drugs — at least in a limited number of cases.

The administration said Thursday that the Department of Health and Human Services will form a working group to look at the idea of in cases in which there is a dramatic price increase for a drug produced by one manufacturer and not protected by patents

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related Books & Audiobooks